<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941019-2-00075</title>
	</head>
	<body>
		<main>
			<p><!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  November 18, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> <!-- PJG STAG 4703 -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>Food and Drug Administration</USBUREAU> <!-- PJG /ITAG -->  <!-- PJG ITAG l=41 g=1 f=1 -->  <RINDOCK>[Docket No. 94N&hyph;0368]</RINDOCK> <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 --> The Upjohn Co., et al.; Withdrawal of Approval of Seven Abbreviated Antibiotic Applications <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <AGENCY> <!-- PJG ITAG l=10 g=1 f=2 --> AGENCY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Food and Drug Administration, HHS. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </AGENCY> <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Notice. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </ACTION> <SUMMARY> <!-- PJG ITAG l=10 g=1 f=2 --> SUMMARY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  The Food and Drug Administration (FDA) is withdrawing approval of seven abbreviated antibiotic applications (AADA's). The holders of the AADA's notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </SUMMARY> <DATE> <!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  November 18, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </DATE> <FURTHER> <!-- PJG ITAG l=10 g=1 f=2 --> FOR FURTHER INFORMATION CONTACT: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Lola E. Batson, Center for Drug Evaluation and Research (HFD&hyph;360), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301&hyph;594&hyph;1038. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </FURTHER> <SUPPLEM> <!-- PJG ITAG l=10 g=1 f=2 --> SUPPLEMENTARY INFORMATION:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  The holders of the AADA's listed in the table in this document have informed FDA that these drug products are no longer marketed and have requested that FDA withdraw approval of the applications. The applicants have also, by their request, waived their opportunity for a hearing. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <TABLE>  <!-- PJG tableformat 3,L1,nj,25C,r50,r50  -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1AADA No.  <!-- PJG 007 0150 intable --> 1Drug  <!-- PJG 007 0150 intable --> 1Applicant <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->   <!-- PJG ITAG l=01 g=1 f=1 --> 61&hyph;651 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Penicillin V Potassium <!-- PJG 0012 frnewline -->  Tablets, U.S.P., 500 milligrams (mg)  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> The Upjohn Co.,  <!-- PJG 0012 frnewline --> 7000 Portage Rd., Kalamazoo, MI  <!-- PJG 0012 frnewline --> 499001&hyph;0199. <!-- PJG 0012 frnewline --> 61&hyph;656 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Penicillin V Potassium for  <!-- PJG 0012 frnewline --> Oral Solution, U.S.P.,  <!-- PJG 0012 frnewline --> 125 mg/5 milliliters (mL)  <!-- PJG 0012 frnewline --> and 250 mg/5 mL <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> 61&hyph;838 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Penicillin G Potassium <!-- PJG 0012 frnewline --> (nonsterile bulk, technical grade) <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> SmithKline Beecham <!-- PJG 0012 frnewline -->  Pharmaceuticals, <!-- PJG 0012 frnewline -->  Four Falls Corporate <!-- PJG 0012 frnewline -->  Center, <!-- PJG 0012 frnewline -->  Rt. 23 and Woodmont Ave., <!-- PJG 0012 frnewline -->  P.O. Box 1510, <!-- PJG 0012 frnewline -->  King of Prussia, PA 19406.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 62&hyph;158 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Bacitracin Ophthalmic  <!-- PJG 0012 frnewline -->  Ointment, U.S.P.,  <!-- PJG 0012 frnewline -->  500 units/gram (g)  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Pharmaderm,  <!-- PJG 0012 frnewline --> Division of Altana Inc.,  <!-- PJG 0012 frnewline --> 60 Baylis Rd., <!-- PJG 0012 frnewline -->  Melville, NY 11747. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 62&hyph;440 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Gentamicin Sulfate <!-- PJG 0012 frnewline -->  Ophthalmic Solution,  <!-- PJG 0012 frnewline -->  U.S.P., 0.3%  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Pharmafair, Inc.,  <!-- PJG 0012 frnewline --> 110 Kennedy Dr.,  <!-- PJG 0012 frnewline --> Hauppauge, NY 11788. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 62&hyph;558 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Erythromycin Ethylsuccinate <!-- PJG 0012 frnewline -->  Oral Suspension, U.S.P., <!-- PJG 0012 frnewline -->  400 mg/5 mL <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline --> 62&hyph;799 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Bacitracin Ointment, U.S.P., <!-- PJG 0012 frnewline -->  500 units/g  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Combe Inc.,  <!-- PJG 0012 frnewline --> 1101 Westchester Ave., <!-- PJG 0012 frnewline -->  White Plains, NY 10604&hyph;3597. <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> Therefore, under section 505(e) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(e)) and under authority delegated to the Director, Center for Drug Evaluation and Research (21 CFR 5.82), approval of the AADA's listed above, and all amendments and supplements thereto, is hereby withdrawn, effective on November 18, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: October 4, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SUPPLEM> <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 -->  Janet Woodcock, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 -->  Director, Center for Drug Evaluation and Research. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;25908 Filed 10&hyph;18&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4160&hyph;01&hyph;F <!-- PJG /ITAG --> </BILLING>  <!-- PJG /STAG --></p>
		</main>
</body></html>
            